Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Integrating T cell metabolism in cancer immunotherapy
Erica Dugnani, Valentina Pasquale, Carlotta Bordignon, et al.
Cancer Letters (2017) Vol. 411, pp. 12-18
Closed Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Potentiating CD8+ T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signaling
Juanjuan Yuan, Ting Cai, Xiaojun Zheng, et al.
Protein & Cell (2021) Vol. 12, Iss. 4, pp. 240-260
Open Access | Times Cited: 106
Car T Cells in Solid Tumors: Overcoming Obstacles
Joselyn Rojas, María P. Díaz, Jim Palmar, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4170-4170
Open Access | Times Cited: 13
Steatohepatitis Impairs T-cell–Directed Immunotherapies Against Liver Tumors in Mice
Bernd Heinrich, Zachary J. Brown, Laurence P. Diggs, et al.
Gastroenterology (2020) Vol. 160, Iss. 1, pp. 331-345.e6
Open Access | Times Cited: 65
NAD-Biosynthetic and Consuming Enzymes as Central Players of Metabolic Regulation of Innate and Adaptive Immune Responses in Cancer
Valentina Audrito, Antonella Managò, Federica Gaudino, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 56
Targeting of chimeric antigen receptor T cell metabolism to improve therapeutic outcomes
Priyanka Maridhi Nanjireddy, Scott H. Olejniczak, Nataliya P. Buxbaum
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
Immunometabolism: Another Road to Sepsis and Its Therapeutic Targeting
Vijay Kumar
Inflammation (2018) Vol. 42, Iss. 3, pp. 765-788
Open Access | Times Cited: 53
Engineering Cell‐Surface Receptors with DNA Nanotechnology for Cell Manipulation
Jiahui Fan, Hong‐Hui Wang, Shiyi Xie, et al.
ChemBioChem (2019) Vol. 21, Iss. 3, pp. 282-293
Closed Access | Times Cited: 46
Immune-mediated anti-tumor effects of metformin; targeting metabolic reprogramming of T cells as a new possible mechanism for anti-cancer effects of metformin
Saman Bahrambeigi, Vahid Shafiei‐Irannejad
Biochemical Pharmacology (2019) Vol. 174, pp. 113787-113787
Closed Access | Times Cited: 46
Immune effects of glycolysis or oxidative phosphorylation metabolic pathway in protecting against bacterial infection
Yan Li, Anna Jia, Yuexin Wang, et al.
Journal of Cellular Physiology (2019) Vol. 234, Iss. 11, pp. 20298-20309
Closed Access | Times Cited: 43
Remodeling of Tumor Immune Microenvironment by Oncolytic Viruses
Bin Zhang, Xilei Wang, Ping Cheng
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 33
Metabolic priming of GD2 TRAC-CAR T cells during manufacturing promotes memory phenotypes while enhancing persistence
Dan Cappabianca, Dan L. Pham, Matthew H. Forsberg, et al.
Molecular Therapy — Methods & Clinical Development (2024) Vol. 32, Iss. 2, pp. 101249-101249
Open Access | Times Cited: 6
Metabolic priming of GD2TRAC-CAR T cells during manufacturing promotes memory phenotypes while enhancing persistence
Dan Cappabianca, Dan L. Pham, Matthew H. Forsberg, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
JAK3 is a potential biomarker and associated with immune infiltration in kidney renal clear cell carcinoma
Feiguo Liang, Hao Liang, Zuwei Li, et al.
International Immunopharmacology (2020) Vol. 86, pp. 106706-106706
Closed Access | Times Cited: 29
Metabolic reprogramming of myeloid-derived suppressor cells: An innovative approach confronting challenges
Xiaoqing Li, Yixue Li, Qinru Yu, et al.
Journal of Leukocyte Biology (2021) Vol. 110, Iss. 2, pp. 257-270
Open Access | Times Cited: 23
Targeting PPAR ligands as possible approaches for metabolic reprogramming of T cells in cancer immunotherapy
Saman Bahrambeigi, Morteza Molaparast, Farahnaz Sohrabi, et al.
Immunology Letters (2020) Vol. 220, pp. 32-37
Closed Access | Times Cited: 19
Tumor Cell-Intrinsic Immunometabolism and Precision Nutrition in Cancer Immunotherapy
Elisabet Cuyàs, Sara Verdura, Begoña Martı́n-Castillo, et al.
Cancers (2020) Vol. 12, Iss. 7, pp. 1757-1757
Open Access | Times Cited: 19
Identification of lncRNA Signature Associated With Pan-Cancer Prognosis
Guoqing Bao, Ran Xu, Xiuying Wang, et al.
IEEE Journal of Biomedical and Health Informatics (2020) Vol. 25, Iss. 6, pp. 2317-2328
Open Access | Times Cited: 18
PPARα Agonist Fenofibrate Enhances Cancer Vaccine Efficacy
Arezki Chekaoui, Hildegund C.J. Ertl
Cancer Research (2021) Vol. 81, Iss. 17, pp. 4431-4440
Open Access | Times Cited: 13
Emerging roles of microRNAs in the metabolic control of immune cells
Qiuming Yao, Zhenyu Song, Bin Wang, et al.
Cancer Letters (2018) Vol. 433, pp. 10-17
Closed Access | Times Cited: 14
Metabolic subtypes and immune landscapes in esophageal squamous cell carcinoma: prognostic implications and potential for personalized therapies
Xiao-wan Yu, Pei-wei She, Fei-Shan Chen, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
TP53-Induced Glycolysis and Apoptosis Regulator (TIGAR) Is Upregulated in Lymphocytes Stimulated with Concanavalin A
Helga Simon‐Molas, Xavier Vallvé, Irene Caldera-Quevedo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7436-7436
Open Access | Times Cited: 10
Nanoimmunotherapy – cloaked defenders to breach the cancer fortress
Gayathri Kandasamy, Vadim V. Annenkov, Uma Maheswari Krishnan
Nanotechnology Reviews (2018) Vol. 7, Iss. 4, pp. 317-340
Open Access | Times Cited: 9
<p>Changes and Clinical Significance of Detailed Peripheral Lymphocyte Subsets in Evaluating the Immunity for Cancer Patients</p>
Jinrong Qiu, Fuping Zhou, Xinchun Li, et al.
Cancer Management and Research (2020) Vol. Volume 12, pp. 209-219
Open Access | Times Cited: 7
The Metabolic Remodelling in Lung Cancer and Its Putative Consequence in Therapy Response
Ana Hipólito, Cindy Mendes, Jacinta Serpa
Advances in experimental medicine and biology (2020), pp. 311-333
Closed Access | Times Cited: 7
Metabolism-Relevant Molecular Classification Identifies Tumor Immune Microenvironment Characterization and Immunotherapeutic Effect in Cervical Cancer
Luyi Li, Hui Gao, Danhan Wang, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top